PPIDT00278
Drug Information
| Name | Antihemophilic factor (recombinant), PEGylated |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB09329 |
| Type | biotech |
| Indication | For the management of hemophilia A (congenital factor VIII deficiency) [FDA label], [A32064]. This medication is a human antihemophilic factor indicated in adolescent and adult patients (12 years and older) with hemophilia A (congenital factor VIII deficiency). It is also used for on-demand treatment and control of bleeding and routine prophylaxis of bleeding episodes. It is not indicated for the treatment of von Willebrand disease [FDA label]. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Kit; powder, for solution | Intravenous |
1000 unit / vial
|
| Kit; powder, for solution | Intravenous |
1500 unit / vial
|
| Kit; powder, for solution | Intravenous |
2000 unit / vial
|
| Kit; powder, for solution | Intravenous |
250 unit / vial
|
| Kit; powder, for solution | Intravenous |
3000 unit / vial
|
| Kit; powder, for solution | Intravenous |
500 unit / vial
|
| Kit; powder, for solution | Intravenous |
750 unit / vial
|
| Injection, powder, lyophilized, for solution | Intravenous |
1000 IU
|
| Injection, powder, lyophilized, for solution | Intravenous |
1500 IU
|
| Injection, powder, lyophilized, for solution | Intravenous |
2000 IU
|
| Injection, powder, lyophilized, for solution | Intravenous |
3000 IU
|
| Injection, powder, lyophilized, for solution | Intravenous |
500 IU
|
| Injection, powder, lyophilized, for solution | Intravenous |
50000000 IU
|
| Injection, powder, lyophilized, for solution | Intravenous |
100000000 IU
|
| Injection, powder, lyophilized, for solution | Intravenous |
200000000 IU
|
| Injection, powder, lyophilized, for solution | Intravenous |
250 IU
|